 Michelle Torok
Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Smoke Pollution | 5 | 2018 | 233 | 1.010 |
Why?
| | Foodborne Diseases | 3 | 2022 | 49 | 0.980 |
Why?
| | Food Safety | 1 | 2022 | 17 | 0.890 |
Why?
| | Child, Hospitalized | 2 | 2018 | 43 | 0.810 |
Why?
| | Gas Poisoning | 1 | 2021 | 5 | 0.800 |
Why?
| | Accidents | 1 | 2021 | 44 | 0.780 |
Why?
| | Parents | 6 | 2020 | 1212 | 0.690 |
Why?
| | Population Surveillance | 2 | 2021 | 413 | 0.690 |
Why?
| | Trichomonas vaginalis | 2 | 2009 | 9 | 0.660 |
Why?
| | Hospitals, Pediatric | 3 | 2018 | 505 | 0.660 |
Why?
| | Public Health | 1 | 2021 | 450 | 0.570 |
Why?
| | Criminals | 1 | 2016 | 31 | 0.550 |
Why?
| | Drug Users | 1 | 2016 | 39 | 0.550 |
Why?
| | Smoking Cessation | 2 | 2018 | 360 | 0.540 |
Why?
| | Substance Abuse, Intravenous | 1 | 2016 | 80 | 0.520 |
Why?
| | Suicide | 1 | 2021 | 500 | 0.510 |
Why?
| | Environmental Exposure | 1 | 2018 | 405 | 0.500 |
Why?
| | Electronic Health Records | 2 | 2018 | 829 | 0.480 |
Why?
| | Violence | 1 | 2016 | 218 | 0.470 |
Why?
| | Patient Readmission | 1 | 2018 | 634 | 0.450 |
Why?
| | Patient Discharge | 1 | 2018 | 796 | 0.420 |
Why?
| | Australia | 3 | 2021 | 212 | 0.420 |
Why?
| | Ganglioglioma | 3 | 2016 | 35 | 0.400 |
Why?
| | Influenza, Human | 4 | 2017 | 554 | 0.380 |
Why?
| | Disease Outbreaks | 5 | 2022 | 322 | 0.360 |
Why?
| | Contraceptives, Oral, Synthetic | 1 | 2009 | 2 | 0.360 |
Why?
| | Trichomonas Infections | 1 | 2009 | 8 | 0.350 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2009 | 30 | 0.350 |
Why?
| | Contraceptives, Oral, Hormonal | 1 | 2009 | 23 | 0.350 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 366 | 0.320 |
Why?
| | Trichomonas Vaginitis | 1 | 2007 | 2 | 0.310 |
Why?
| | Lactobacillus | 1 | 2007 | 23 | 0.310 |
Why?
| | Young Adult | 15 | 2021 | 10793 | 0.310 |
Why?
| | Sexually Transmitted Diseases | 1 | 2009 | 155 | 0.300 |
Why?
| | Hospitalization | 6 | 2018 | 1785 | 0.300 |
Why?
| | Adolescent | 22 | 2023 | 18480 | 0.280 |
Why?
| | Smoke | 2 | 2018 | 143 | 0.280 |
Why?
| | Female | 32 | 2021 | 61565 | 0.280 |
Why?
| | Vagina | 1 | 2007 | 148 | 0.270 |
Why?
| | Child | 22 | 2020 | 19129 | 0.270 |
Why?
| | Male | 30 | 2021 | 57801 | 0.270 |
Why?
| | Colorado | 9 | 2023 | 4196 | 0.260 |
Why?
| | Child, Preschool | 20 | 2020 | 9491 | 0.260 |
Why?
| | Housing | 2 | 2017 | 123 | 0.260 |
Why?
| | Adult | 17 | 2023 | 31512 | 0.250 |
Why?
| | Hydronephrosis | 2 | 2015 | 30 | 0.250 |
Why?
| | Infant | 18 | 2020 | 8293 | 0.250 |
Why?
| | Influenza A Virus, H1N1 Subtype | 2 | 2016 | 140 | 0.250 |
Why?
| | Marijuana Smoking | 2 | 2018 | 220 | 0.250 |
Why?
| | Neurosurgical Procedures | 2 | 2015 | 164 | 0.240 |
Why?
| | Humans | 39 | 2023 | 118974 | 0.240 |
Why?
| | Substance-Related Disorders | 1 | 2012 | 971 | 0.230 |
Why?
| | Arizona | 1 | 2022 | 69 | 0.220 |
Why?
| | Middle Aged | 12 | 2021 | 27617 | 0.220 |
Why?
| | Craniopharyngioma | 2 | 2014 | 70 | 0.220 |
Why?
| | Influenza Vaccines | 2 | 2017 | 500 | 0.210 |
Why?
| | Data Collection | 3 | 2014 | 658 | 0.210 |
Why?
| | Pituitary Neoplasms | 2 | 2014 | 165 | 0.210 |
Why?
| | Specimen Handling | 1 | 2022 | 165 | 0.200 |
Why?
| | Inpatients | 3 | 2020 | 388 | 0.200 |
Why?
| | SEER Program | 4 | 2018 | 205 | 0.200 |
Why?
| | Carbon Monoxide Poisoning | 1 | 2021 | 6 | 0.200 |
Why?
| | Surveys and Questionnaires | 5 | 2017 | 4708 | 0.190 |
Why?
| | Information Systems | 1 | 2021 | 66 | 0.190 |
Why?
| | Smoke-Free Policy | 2 | 2017 | 15 | 0.190 |
Why?
| | Age Distribution | 1 | 2021 | 362 | 0.180 |
Why?
| | Databases, Factual | 3 | 2021 | 1231 | 0.180 |
Why?
| | Sex Distribution | 1 | 2021 | 351 | 0.180 |
Why?
| | Cotinine | 2 | 2018 | 76 | 0.180 |
Why?
| | Retrospective Studies | 13 | 2018 | 12978 | 0.180 |
Why?
| | Asthma | 3 | 2018 | 2158 | 0.170 |
Why?
| | Occipital Bone | 1 | 2018 | 20 | 0.170 |
Why?
| | Atlanto-Axial Joint | 1 | 2018 | 17 | 0.170 |
Why?
| | Tobacco Smoking | 1 | 2018 | 22 | 0.170 |
Why?
| | Vaccination | 2 | 2017 | 1222 | 0.170 |
Why?
| | Risk Factors | 7 | 2016 | 9000 | 0.170 |
Why?
| | Infant, Newborn | 10 | 2020 | 5255 | 0.160 |
Why?
| | Directive Counseling | 1 | 2018 | 42 | 0.160 |
Why?
| | Conversion Disorder | 1 | 2018 | 10 | 0.160 |
Why?
| | Brain Neoplasms | 2 | 2016 | 1022 | 0.160 |
Why?
| | Bone Transplantation | 1 | 2018 | 99 | 0.160 |
Why?
| | Polypharmacy | 1 | 2018 | 75 | 0.160 |
Why?
| | Bronchiolitis | 1 | 2018 | 83 | 0.150 |
Why?
| | Cervical Vertebrae | 1 | 2018 | 115 | 0.150 |
Why?
| | Health Personnel | 2 | 2017 | 588 | 0.150 |
Why?
| | Disease Notification | 2 | 2007 | 15 | 0.150 |
Why?
| | Air Pollution, Indoor | 1 | 2018 | 117 | 0.150 |
Why?
| | Meningioma | 1 | 2018 | 82 | 0.150 |
Why?
| | Medical Marijuana | 1 | 2018 | 102 | 0.150 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 90 | 0.150 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6561 | 0.150 |
Why?
| | Joint Instability | 1 | 2018 | 172 | 0.140 |
Why?
| | Medical Audit | 1 | 2016 | 75 | 0.140 |
Why?
| | Personal Satisfaction | 1 | 2017 | 188 | 0.140 |
Why?
| | Supratentorial Neoplasms | 1 | 2015 | 20 | 0.140 |
Why?
| | Ketorolac | 1 | 2015 | 18 | 0.130 |
Why?
| | Spinal Fusion | 1 | 2018 | 225 | 0.130 |
Why?
| | Home Care Services | 1 | 2018 | 217 | 0.130 |
Why?
| | Enterovirus D, Human | 1 | 2016 | 76 | 0.130 |
Why?
| | Temporal Lobe | 1 | 2015 | 90 | 0.130 |
Why?
| | Case-Control Studies | 3 | 2023 | 3171 | 0.130 |
Why?
| | Seizures | 1 | 2018 | 345 | 0.130 |
Why?
| | Prevalence | 4 | 2020 | 2326 | 0.130 |
Why?
| | Intracranial Hemorrhages | 1 | 2015 | 77 | 0.130 |
Why?
| | Postnatal Care | 1 | 2015 | 68 | 0.130 |
Why?
| | Choroid Plexus Neoplasms | 1 | 2014 | 9 | 0.130 |
Why?
| | Social Support | 1 | 2018 | 542 | 0.130 |
Why?
| | Brain Stem Neoplasms | 1 | 2015 | 90 | 0.130 |
Why?
| | Perioperative Care | 1 | 2015 | 132 | 0.120 |
Why?
| | Epilepsy | 1 | 2018 | 290 | 0.120 |
Why?
| | Attitude to Health | 1 | 2017 | 410 | 0.120 |
Why?
| | Enterovirus Infections | 1 | 2016 | 164 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2674 | 0.120 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.120 |
Why?
| | Length of Stay | 2 | 2015 | 1032 | 0.120 |
Why?
| | Smoking | 2 | 2018 | 1487 | 0.120 |
Why?
| | Central Nervous System Neoplasms | 1 | 2015 | 128 | 0.110 |
Why?
| | Health Surveys | 2 | 2012 | 454 | 0.110 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 304 | 0.110 |
Why?
| | Neurology | 1 | 2014 | 94 | 0.110 |
Why?
| | Comorbidity | 2 | 2015 | 1527 | 0.100 |
Why?
| | Citrullus | 1 | 2010 | 1 | 0.100 |
Why?
| | Salmonella Food Poisoning | 1 | 2010 | 11 | 0.100 |
Why?
| | Cytokines | 1 | 2018 | 1900 | 0.100 |
Why?
| | Aged | 6 | 2021 | 19657 | 0.100 |
Why?
| | Age of Onset | 1 | 2012 | 467 | 0.090 |
Why?
| | Time Factors | 2 | 2018 | 6412 | 0.090 |
Why?
| | Societies, Medical | 1 | 2014 | 703 | 0.090 |
Why?
| | Surgeons | 1 | 2014 | 243 | 0.090 |
Why?
| | Biomarkers | 2 | 2018 | 3588 | 0.090 |
Why?
| | Pneumonia | 1 | 2015 | 592 | 0.090 |
Why?
| | Alabama | 1 | 2009 | 24 | 0.090 |
Why?
| | Salmonella typhimurium | 1 | 2010 | 174 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2007 | 1185 | 0.080 |
Why?
| | Biomedical Research | 1 | 2014 | 612 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 1353 | 0.080 |
Why?
| | Vaginosis, Bacterial | 1 | 2007 | 13 | 0.080 |
Why?
| | Infection Control Practitioners | 1 | 2007 | 10 | 0.080 |
Why?
| | Cross-Sectional Studies | 3 | 2014 | 4552 | 0.080 |
Why?
| | Food Microbiology | 1 | 2007 | 59 | 0.080 |
Why?
| | Colony Count, Microbial | 1 | 2007 | 120 | 0.080 |
Why?
| | Communicable Disease Control | 1 | 2007 | 72 | 0.070 |
Why?
| | Education | 1 | 2007 | 105 | 0.070 |
Why?
| | Blastomyces | 1 | 2006 | 8 | 0.070 |
Why?
| | Blastomycosis | 1 | 2006 | 9 | 0.070 |
Why?
| | Lung Diseases, Fungal | 1 | 2006 | 14 | 0.070 |
Why?
| | Dronabinol | 2 | 2018 | 121 | 0.070 |
Why?
| | Food Hypersensitivity | 1 | 2010 | 260 | 0.070 |
Why?
| | Dog Diseases | 1 | 2006 | 44 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2009 | 1293 | 0.070 |
Why?
| | Cohort Studies | 4 | 2018 | 5116 | 0.070 |
Why?
| | Diarrhea | 1 | 2007 | 181 | 0.070 |
Why?
| | United States | 6 | 2017 | 12555 | 0.060 |
Why?
| | Accommodation, Ocular | 1 | 2023 | 11 | 0.060 |
Why?
| | Sexual Behavior | 1 | 2007 | 437 | 0.060 |
Why?
| | North Carolina | 3 | 2007 | 109 | 0.050 |
Why?
| | Treatment Outcome | 4 | 2018 | 9342 | 0.050 |
Why?
| | Prospective Studies | 2 | 2014 | 6471 | 0.050 |
Why?
| | Follow-Up Studies | 3 | 2015 | 4596 | 0.050 |
Why?
| | New Zealand | 2 | 2010 | 50 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 2015 | 1166 | 0.050 |
Why?
| | Socioeconomic Factors | 2 | 2017 | 1129 | 0.050 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 63 | 0.040 |
Why?
| | Animals | 3 | 2009 | 33381 | 0.040 |
Why?
| | Age Factors | 2 | 2018 | 2995 | 0.040 |
Why?
| | Limit of Detection | 1 | 2016 | 55 | 0.040 |
Why?
| | Tertiary Healthcare | 1 | 2016 | 28 | 0.040 |
Why?
| | Urinalysis | 1 | 2016 | 68 | 0.040 |
Why?
| | Electroencephalography | 1 | 2018 | 387 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 272 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2020 | 648 | 0.030 |
Why?
| | Prognosis | 2 | 2015 | 3443 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 996 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2016 | 157 | 0.030 |
Why?
| | Immunization Schedule | 1 | 2016 | 188 | 0.030 |
Why?
| | Magnesium | 1 | 2015 | 150 | 0.030 |
Why?
| | Hospital Costs | 1 | 2015 | 110 | 0.030 |
Why?
| | Administration, Intravenous | 1 | 2015 | 136 | 0.030 |
Why?
| | Cost of Illness | 1 | 2016 | 258 | 0.030 |
Why?
| | Steroids | 1 | 2015 | 153 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2015 | 258 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 473 | 0.030 |
Why?
| | Community-Acquired Infections | 1 | 2015 | 143 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1384 | 0.030 |
Why?
| | Mass Screening | 1 | 2020 | 1052 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 649 | 0.030 |
Why?
| | Carcinoma | 1 | 2014 | 204 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 842 | 0.030 |
Why?
| | Cannabis | 1 | 2018 | 382 | 0.030 |
Why?
| | Residence Characteristics | 1 | 2014 | 299 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1125 | 0.030 |
Why?
| | Logistic Models | 1 | 2016 | 1901 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2014 | 749 | 0.020 |
Why?
| | Critical Illness | 1 | 2016 | 662 | 0.020 |
Why?
| | Sex Factors | 1 | 2016 | 1781 | 0.020 |
Why?
| | Ultrasonography | 1 | 2015 | 716 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1267 | 0.020 |
Why?
| | Bacteriophage Typing | 1 | 2010 | 2 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2015 | 523 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2014 | 1474 | 0.020 |
Why?
| | Pediatrics | 1 | 2017 | 985 | 0.020 |
Why?
| | Survival Rate | 1 | 2012 | 1720 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 2874 | 0.020 |
Why?
| | Food Contamination | 1 | 2007 | 45 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1440 | 0.020 |
Why?
| | Clinical Laboratory Techniques | 1 | 2007 | 89 | 0.020 |
Why?
| | Laboratories | 1 | 2007 | 97 | 0.020 |
Why?
| | Communicable Diseases | 1 | 2007 | 132 | 0.020 |
Why?
| | Dogs | 1 | 2006 | 371 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2007 | 546 | 0.020 |
Why?
| | Feces | 1 | 2007 | 396 | 0.020 |
Why?
| | Acute Disease | 1 | 2007 | 940 | 0.010 |
Why?
| | Counseling | 1 | 2007 | 353 | 0.010 |
Why?
| | Rural Population | 1 | 2006 | 452 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2007 | 699 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2007 | 1200 | 0.010 |
Why?
|
|
Torok's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|